The Genomic Grade Index (GGI) – a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial
C. Desmedt, A. Giobbie-Hurder, P. Neven, R. Paridaens, M.R. Christiaens, A. Smeets, F. Lallemand, M. Piccart, R. Gelber, C. SotiriouVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70797-3
File:
PDF, 56 KB
english, 2008